Observation arm

DRUG5 trials

Sponsors

University of Pennsylvania, Peking University, Assiut University, PENG YUAN, Ghent University

Conditions

ALLAMLCMLDigestive System Nutritional, Metabolic, Endocrine Pregnancy and ChildbirthHepatitis BHodgkin's DiseaseIVFLocally Advanced

Phase 1

Umbilical Cord Blood Transplant for Hematological Malignancies

CompletedNCT00891592

University of PennsylvaniaALL, AML, CML +4

Start: 2009-01-31End: 2016-05-31Updated: 2016-08-19

Phase 2

Maternal Probiotic Intervention to Improve Gut Health-Trial II (MPIGH-II)

Active, not recruitingPACTR202404835984424

Ghent UniversityDigestive System Nutritional, Metabolic, Endocrine Pregnancy and Childbirth

Start: 2024-10-01Target: 144Updated: 2026-09-14

Phase 4

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Peking UniversityHepatitis B

Start: 2013-01-31End: 2017-12-31Target: 190Updated: 2017-01-10

Unknown Phase

Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer

Active, not recruitingNCT06577181

Assiut UniversityIVF

Start: 2024-05-10End: 2026-05-10Target: 50Updated: 2024-09-19

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

Not yet recruitingNCT07046780

PENG YUANLocally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer

Start: 2025-07-30End: 2027-12-30Target: 90Updated: 2025-07-02